BioXchange
- Other products or services
Representing AsymBio at BIO.
AsymBio is a global biologics CDMO focused on supporting clients with ADC, mAb, and other protein-based needs regarding from the stages of pre-clinical to commercial manufacturing. AsymBio's parent company is Aymchem (a global CDMO). Asymchem's other portfolio companies include Yugen Medtech (pre-clinical CRO) and Clin-Nov (clinical trial CRO).
Founded in 2018, BioXchange is one of Boston's largest biotech networking organizations. Pre-pandemic, monthly in-person events hosted 150-200 people. Since the pandemic, events have been hosted monthly with over 100 in monthly attendence.
a part of Asymchem (a global full service CDMO). We support clients with mAbs, ADCs, and plasmids needs with our commercial manufacturing site just coming online this year.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}